导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.41% | 3538/4981 |
| 近一周 | -4.75% | 5304/5421 |
| 近一月 | -5.17% | 2278/5424 |
| 近一季 | -1.57% | 1337/5380 |
| 近半年 | -17.87% | 4714/5140 |
| 近一年 | -0.52% | 2700/4741 |
| 近两年 | 43.36% | 2604/4207 |
| 近三年 | -4.00% | 3167/3662 |
| 成立以来 | 295.06% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.76% 604/5130 |
-10.43% 4468/5464 |
- - |
- - |
| 2025 | 36.56% 1703/5130 |
1.92% 2963/4624 |
7.16% 817/4802 |
25.83% 2092/4970 |
-0.63% 2145/5130 |
| 2024 | -9.55% 3590/4618 |
-3.26% 2192/4340 |
-5.84% 3276/4442 |
3.75% 3984/4550 |
-4.30% 2913/4618 |
| 2023 | -21.57% 2808/4216 |
6.30% 750/3759 |
-7.41% 2871/3909 |
-5.29% 1404/4055 |
-15.87% 4025/4209 |
| 2022 | -18.82% 1002/3578 |
-17.35% 1351/2804 |
3.00% 2349/3205 |
-11.77% 1500/3430 |
8.08% 344/3570 |
| 2021 | 35.98% 98/2717 |
2.82% 151/1745 |
8.32% 1107/2232 |
5.61% 325/2560 |
15.61% 27/2708 |
| 2020 | 47.22% 644/1596 |
-2.68% 587/1036 |
6.37% 1011/1256 |
21.42% 83/1472 |
17.13% 476/1690 |
| 2019 | 41.50% 381/926 |
21.07% 1293/3054 |
-5.08% 2576/3201 |
7.79% 338/939 |
14.23% 117/1014 |
| 2018 | -27.09% 362/668 |
- - |
- - |
- - |
-13.66% 2605/2977 |
| 2017 | 22.34% 138/531 |
- - |
- - |
- - |
- - |
| 2016 | -28.61% 396/455 |
- - |
- - |
- - |
- - |
| 2015 | 66.70% 86/433 |
- - |
- - |
- - |
- - |
| 2014 | 24.98% 201/432 |
- - |
- - |
- - |
- - |
| 2013 | 24.77% 95/398 |
- - |
- - |
- - |
- - |
| 2012 | 3.18% 275/459 |
- - |
- - |
- - |
- - |
| 2011 | -25.66% 259/392 |
- - |
- - |
- - |
- - |
| 2010 | 17.63% 39/335 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 56.52% |
| 招商创新增长混合A | 1.0759 | 55.91% |
| 招商创新增长混合C | 1.0235 | 55.61% |
| 招商品质成长混合A | 1.0435 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6422 | 50.99% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 48.05% |
| 大摩优悦安和混合C | 0.8828 | 47.91% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 中信建投医药健康C | 0.7579 | 39.35% |
| 天弘周期策略混合A VS. 长安宏观策略混合A(740001) |